DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Tovetumab
Tovetumab
Predictive QSAR Tools to Aid in Early Process Development of Monoclonal Antibodies
Classification Decisions Taken by the Harmonized System Committee from the 47Th to 60Th Sessions (2011
The Two Tontti Tudiul Lui Hi Ha Unit
NSCLC Therapeutics in Asia-Pacific Markets to 2019 Personalized Therapies Focus on Untapped Segment of Squamous Cell Carcinoma to Expand Treatment Pool
WO 2016/176089 Al 3 November 2016 (03.11.2016) P O P C T
US10851148.Pdf
(INN) for Biological and Biotechnological Substances
United States Patent (10 ) Patent No.: US 10,471,211 B2 Rusch Et Al
WO 2016/127220 Al 18 August 2016 (18.08.2016) P O P C T
Stembook 2018.Pdf
Proceedings of the Second NCI–SNMMI Workshop on Targeted Radionuclide Therapy
(INN) for Biological and Biotechnological Substances
(19) United States (12) Patent Application Publication (10) Pub
6.6.2018 a Abacavir Abacavirum Abakaviiri Abagovomab
International Nonproprietary Names (INN) for Biological and Biotechnological Substances
International Nonproprietary Names for Pharmaceutical Substances (INN)
LTR-16-0131 Hossein Jadvar, President, Society of Nuclear
NCI-SNMMI Workshop on Targeted Radionuclide Therapy
Top View
(12) Patent Application Publication (10) Pub. No.: US 2017/0173267 A1 Ashmead Et Al
Supplementary Tables and Figures Section 1. Distribution of CDR-H3
Looking for Therapeutic Antibodies in Next Generation Sequencing Repositories
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
(INN) for Biological and Biotechnological Substances
WO 2015/036956 Al 19 March 2015 (19.03.2015) P O P C T
INN-Nimet 1 20.8.2019 a Abacavir Abacavirum Abakaviiri
(12) Patent Application Publication (10) Pub. No.: US 2015/0374790 A1 Liu Et Al